Menu
Home
Forums
Forums

Quick Links
- Search Forums
- Recent Posts
job center
job ratings
catering
webinars
legal help
advertise on CP
submit press release
Menu

Log in
Sign up
Search titles only

Posted by Member:

Separate names with a comma.

Newer Than:

Search this thread only

Search this forum only

Display results as threads

More...

Useful Searches

Recent Posts

Will virtual biotech conferences become the new reality? — AstraZeneca defends slow vaccine supplies to the EU — Upcoming FDA oncology decisions — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
Dismiss Notice

pillow

Discussion in 'Teva Neuroscience' started by anonymous, Aug 16, 2018 at 2:21 PM.

Tags: Edit

#1 anonymous, Aug 16, 2018 at 2:21 PM

anonymous Guest

Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will end the monopoly of Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis
https://news.alphastreet.com/teva-pharmaceuticals-fda-approval-epipen-generic/

Quote

Reply to Thread